Follow-The-Filings

Security · featured owners

ORKA Oruka Therapeutics Inc.

COM Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 11.6%
  • $219M
  • 2 reduce

Who owns this now

Largest portfolio weights among featured holders · max 11.6% (David Witzke - Avidity Pa...) · not free-float ownership

  1. David Witzke 11.6%
  2. Palo Alto Investors reduce 0.44%
  3. Andreas Halvorsen reduce 0.41%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Andreas Halvorsen - Viking Global Investors 2026 Q2 0.41% Reduce −43.6% 1,503,478 $143M history
David Witzke - Avidity Partners Management 2026 Q2 11.6% Hold 760,424 $72M history
Palo Alto Investors 2026 Q2 0.44% Reduce −44.1% 33,546 $3M history

3 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $0.00 — —
Net income -$5.34M -$83.72M -$105.43M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $37.59M $1,000 $343.86M
Total non-current assets * $269,000 $0.00 $144.76M
Total assets $37.86M $1,000 $488.62M
Total current liabilities $637,000 $13.04M $15.37M
Total non-current liabilities * $204,000 $755,000 $1.31M
Total equity $37.02M $1,000 $471.93M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$5.01M -$57.84M -$88.21M
Cash from investing $0.00 -$330.13M -$96.74M
Cash from financing $0.00 $449.54M $170.32M
Net change in cash * -$5.01M $61.58M -$14.64M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders